Non-Valvular Atrial Fibrillation Management: How Superior Efficacy and Bleeding Risk Data Are Cementing Apixaban Market Dominance

добавлена новая статья Health

2025-12-02 12:58:00 -

The Apixaban Market is experiencing remarkable market growth, driven largely by its superior convenience and positive impact on patient adherence compared to legacy anticoagulants. Older therapies, such as Vitamin K antagonists, require frequent blood monitoring, dietary restrictions, and complex dose adjustments, often leading to poor patient compliance and inconsistent therapeutic effects,...

0 Комментарии 0 Поделились 238 Просмотры 0 предпросмотр